Preliminary Exploration of <i>MAGE-B1</i>, <i>-B4</i>, <i>-B5</i>, and <i>-B10</i> mRNA Expression in Canine Mammary Tumors in Dogs

Preliminary Exploration of <i>MAGE-B1</i>, <i>-B4</i>, <i>-B5</i>, and <i>-B10</i> mRNA Expression in Canine Mammary Tumors in Dogs

The melanoma-associated antigen gene (MAGE) is a key target in cancer immunotherapy. Given the potential of MAGE-B genes in veterinary immunotherapy for canine mammary tumors (CMTs), this study investigated the mRNA expression of <i>MAGE-B1</i>, <i>-B4</i>, <i>-B5</i...

Full description

Saved in:
Bibliographic Details
Main Authors: Wanwisa Srisawat, Pongpisid Koonyosying, Anucha Muenthaisong, Kanokwan Sangkakam, Thanya Varinrak, Nattawooti Sthitmatee
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Animals
Subjects:
canine mammary tumors
melanoma-associated antigen-B
mRNA expression
quantitative real-time PCR
Online Access:https://www.mdpi.com/2076-2615/15/7/910
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The melanoma-associated antigen gene (MAGE) is a key target in cancer immunotherapy. Given the potential of MAGE-B genes in veterinary immunotherapy for canine mammary tumors (CMTs), this study investigated the mRNA expression of <i>MAGE-B1</i>, <i>-B4</i>, <i>-B5</i>, and <i>-B10</i> in CMT tissues and cells from dogs. Quantitative real-time PCR was used to analyze 28 CMT tissue samples, including 4 benign and 24 malignant tumors (13 simple carcinomas, 6 complex carcinomas, 3 carcinosarcomas, and 2 fibrosarcomas). Benign mixed tumor and complex carcinoma-type CMT cells were cultured and treated with a DNA methylase inhibitor (5-aza-2′-deoxycytidine; 5-aza-CdR) and a histone deacetylase inhibitor (Trichostatin A; TSA) under the following four conditions: (1) 5-aza-CdR for 72 h; (2) TSA for 24 h; (3) 5-aza-CdR for 48 h followed by TSA for 24 h; and (4) control. <i>MAGE-B1</i> and <i>-B4</i> showed the highest expression in the CMT samples (100% and 89.29%, respectively), followed by <i>MAGE-B10</i> (82.14%). Carcinosarcomas and simple anaplastic carcinomas had significantly higher MAGE-B expression levels than simple tubulopapillary carcinomas (<i>p</i> < 0.05). 5-aza-CdR treatment increased MAGE-B expression, whereas TSA had a mild effect. Further research involving larger cohorts is needed to confirm these findings.
ISSN:2076-2615

Similar Items